Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -9.67% | 1.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.67% | 1.54% | |||
| Cost of Revenue | -13.91% | 7.99% | |||
| Gross Profit | 4.94% | -15.79% | |||
| SG&A Expenses | -18.11% | 10.99% | |||
| Depreciation & Amortization | -2.19% | 67.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.01% | 13.18% | |||
| Operating Income | 66.92% | -385.03% | |||
| Income Before Tax | 45.02% | -69.42% | |||
| Income Tax Expenses | -158.45% | 346.96% | |||
| Earnings from Continuing Operations | 48.47% | -78.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 48.47% | -78.58% | |||
| EBIT | 66.92% | -385.03% | |||
| EBITDA | 181.63% | -259.01% | |||
| EPS Basic | 48.53% | -51.11% | |||
| Normalized Basic EPS | 46.34% | -355.56% | |||
| EPS Diluted | 52.05% | -1.39% | |||
| Normalized Diluted EPS | 46.34% | -355.56% | |||
| Average Basic Shares Outstanding | 1.20% | 16.77% | |||
| Average Diluted Shares Outstanding | 1.20% | 16.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||